SCHEMBL6922901

SCHEMBL6922901

COCC(=O)Nc1ccc2[nH]c3c(N4CCN(CCc5ccc(F)c(F)c5)CC4)ncnc3c2c1

nearest known ligand 0.82

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ABCC1 P33527 18/20 0.82
CYP3A4 P08684 8/20 0.74
ABCB1 P08183 2/20 0.61
KDM4E B2RXH2 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ABCG2 Q9UNQ0 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
GALR2 O43603 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6924095 0.88 ABCC1 (0.79) ABCC1CYP3A4ABCB1KDM4ESMN1; SMN2
SCHEMBL6923315 0.88 ABCC1 (0.84) ABCC1CYP3A4ABCB1KDM4ESMN1; SMN2
SCHEMBL6923424 0.86 ABCC1 (0.81) ABCC1CYP3A4ABCB1KDM4ESMN1; SMN2
SCHEMBL6827154 0.85 ABCC1 (1.00) ABCC1CYP3A4ABCB1KDM4ESMN1; SMN2
SCHEMBL6925209 0.84 ABCC1 (0.73) ABCC1CYP3A4ABCB1KDM4ESMN1; SMN2
SCHEMBL6922763 0.84 ABCC1 (0.77) ABCC1CYP3A4ABCB1KDM4ESMN1; SMN2
SCHEMBL6922256 0.84 ABCC1 (0.77) ABCC1CYP3A4ABCB1KDM4ESMN1; SMN2
SCHEMBL6919927 0.83 ABCC1 (0.75) ABCC1CYP3A4ABCB1ABCG2
SCHEMBL6826366 0.82 ABCC1 (1.00) ABCC1CYP3A4ABCB1KDM4EABCG2
SCHEMBL6918220 0.82 ABCC1 (0.86) ABCC1CYP3A4ABCB1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004111052-A1 PYRROLOPYRIMIDINE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE (MDR) XENOVA LIMITED (GB) 2004-12-23 WO claimed
WO-2004111052-A1 PYRROLOPYRIMIDINE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE (MDR) XENOVA LIMITED (GB) 2004-12-23 WO disclosed